Raji-HER2 cells | ADCC target cells | InvivoGen
PLOS ONE: Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive Assay for Monitoring Breast Cancer Progression
Breast cancer: a new target? | Recherche animale
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness | HTML
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence - Shi - 2019 - Cancer Medicine - Wiley Online Library
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer - Annals of Oncology
IVD Antibody & Immunoassay Development Services for HER2 Biomarker - Creative Biolabs
Breast cancer: a new target? | Recherche animale
PLOS ONE: High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
Real-time detection of cancer marker, HER2, using a... | Download Scientific Diagram
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports
PLOS ONE: HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Increased expression of proliferation markers and her2/neu in neuT-C3... | Download Scientific Diagram
Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy | Scientific Reports
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
BMS-599626 (AC480), HER1 and HER2 inhibitor (ab142063) | アブカム
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response | Nature Cancer
Identification of gene markers for HER2+, Luminal A/B and TNBC. (A)... | Download Scientific Diagram
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - eBioMedicine
-Western-Blot-NBP2-34472-img0007.jpg "ErbB2/Her2 Antibody (CL0269) (NBP2-34472): Novus Biologicals")
ErbB2/Her2 Antibody (CL0269) (NBP2-34472): Novus Biologicals
Mitochondrial MKP1 Is a Target for Therapy-Resistant HER2-Positive Breast Cancer Cells | Cancer Research
